45 results
8-K
EX-99.2
ME
23andMe Holding Co - Ordinary Shares
8 Jan 24
Regulation FD Disclosure
7:45am
to approval Experienced, innovative genetics researchers and clinical development team with track record for innovative approvals Genetics
DEFR14A
ME
23andMe Holding Co - Ordinary Shares
26 Jul 23
Revised proxy
9:14pm
high integrity, an appreciation for diversity of background and thought, innovative thinking, a proven record of success, and deep knowledge
424B3
81q2vdpx
7 Nov 22
Prospectus supplement
4:33pm
8-K
EX-99.1
d2iaz60rhcdory
18 Aug 22
Investor Presentation August 2022
4:06pm
424B3
oin8sok 86l54np
16 Aug 22
Prospectus supplement
6:12pm
DEF 14A
g3zlb
15 Jul 22
Definitive proxy
8:05am
424B3
dk0cgu8jg5ylqq
27 May 22
Prospectus supplement
4:52pm
8-K
EX-99.1
twk5zuwbm99kis2s8
23 Feb 22
Regulation FD Disclosure
9:31am
424B3
7i6cm05o
11 Feb 22
Prospectus supplement
2:01pm
8-K
EX-99.1
urgmp8ii
18 Jan 22
Regulation FD Disclosure
8:15am
424B3
b6sz0w8pdsy
10 Nov 21
Prospectus supplement
5:00pm